Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Perform Rating from William Blair
Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report)‘s stock had its “market perform” rating reiterated by equities researchers at William Blair in a research report issued on Friday,RTT News reports. A number of other equities analysts also recently weighed in on TERN. JMP Securities reaffirmed a “market outperform” rating and issued a $20.00 price target on […]
Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report)‘s stock had its “market perform” rating reiterated by equities researchers at William Blair in a research report issued on Friday,RTT News reports. A number of other equities analysts also recently weighed in on TERN. JMP Securities reaffirmed a “market outperform” rating and issued a $20.00 price target on […]
